United States: Glaxo gets WHO approval for Synflorix vaccine.Byline: Mamta03 British drugmaker GlaxoSmithKline (GSK GSK GlaxoSmithKline plc (pharmaceutical company) GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) .L) said on Friday it had received approval from the World Health Organization (WHO) for its pneumonia vaccine, clearing the way for it to be given to children in the developing world. The vaccine, Synflorix, is the first of its kind to receive the WHO "prequalification" designation. It is used to treat pneumococcal pneumococcal /pneu·mo·coc·cal/ (-kok´al) pertaining to or caused by pneumococci. disease, a bacterial infection which can result in conditions such as pneumonia and meningitis meningitis (mĕnĭnjī`tĭs) or cerebrospinal meningitis (sĕr'əbrōspī`nəl), acute inflammation of the meninges, the membranes that cover and protect the brain and spinal cord. in children. The vaccine, which was approved by European authorities in March, competes with Pfizer's (PFE 1. (text, editor) PFE - Programmer's File Editor. 2. (language) PFE - Portable Forth Environment. .N) market-leading Prevnar, which generated worldwide sales of $2.7 billion in 2008. Copyright : Euclid Infotech Pvt. Ltd. Provided by Syndigate.info an Albawaba.com company |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion